日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

撤稿声明:BICC1通过诱导不依赖于VEGF的血管生成来驱动胰腺癌进展。

Huang, Chongbiao; Li, Hui; Xu, Yang; Xu, Chao; Sun, Huizhi; Li, Zengxun; Ge, Yi; Wang, Hongwei; Zhao, Tiansuo; Gao, Song; Wang, Xiuchao; Yang, Shengyu; Sun, Peiqing; Liu, Zhe; Liu, Jing; Chang, Antao; Hao, Jihui

First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFR-mutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial

一线治疗EGFR突变型非小细胞肺癌患者,比较奥莫替尼(EGFR酪氨酸激酶抑制剂)联合阿帕替尼(VEGFR抑制剂)与奥莫替尼单药治疗的疗效:一项随机、多中心、II期临床试验

Zhang, Fan; Zheng, Zhendong; Zhang, Hongmei; Yan, Xiaolong; Liu, Zhefeng; Yang, Fan; Wen, Juyi; Gan, Xin; Wu, Lin; Cang, Shundong; Wang, Hongmei; Zhao, Jun; Peng, Liang; Li, Xiaosong; Fan, Zaiwen; Shen, Ge; Zhou, Qiong; Zou, Jinjing; Xu, Yu; Zhang, Lei; Zhao, Mingfang; Cai, Shangli; Hu, Yi

GlycoRNA complexed with heparan sulfate regulates VEGF-A signalling.

糖RNA与硫酸乙酰肝素复合物调节VEGF-A信号传导。

Chai Peiyuan, Kheiri Sina, Kuo Andrew, Shah Jessica, Kageler Lauren, Ge Ruiqi, Perr Jonathan, Porat Jennifer, Lebedenko Charlotta G, Dias Joao M L, Yankova Eliza, Rai Sandeep K, Watkins Christopher P, Hristov Petar, Tzelepis Konstantinos, Hla Timothy, Raman Ritu, Calo Eliezer, Esko Jeffrey D, Flynn Ryan A

Correction: Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling

更正:组蛋白去甲基化酶KDM4D通过HIF1β/VEGFA信号通路促进胃肠道间质瘤进展

Hu, Fuqing; Li, Haijie; Liu, Lu; Xu, Feng; Lai, Senyan; Luo, Xuelai; Hu, Junbo; Yang, Xi

Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia.

在空间受限的导管内靶向抑制 VEGFR2 可促进神经自我修复并缓解机械性痛觉过敏。

Luo Xiaobin, Nagayasu Toshitatsu, Zhang Yuhao, He Zhi, Yang Jia, Li Chengli, Duan Guman, Zong Qunchuan, Liu Yun, Yang Kaiyuan, Mao Kaige, Ma Pengchao, Li Zifan, Zhao Yating, Kim KunKoo, Zhang Jie, Wang Zide, Luo Yuyang, Lu Jingsong, Tong Sengpav, Yu Jia-Kuo, Zhao Zhe, Cao Zheng, Yang Shuhui, Pan Yongwei, Wang Xiumei

Aminated fullerene-based nanoplatform enables synergistic VEGFR2-targeted anti-angiogenesis and tumor immunotherapy.

基于氨基化富勒烯的纳米平台可实现协同的 VEGFR2 靶向抗血管生成和肿瘤免疫治疗。

Huo Jiawei, Wang Yijun, Liu Lei, Li Jie, Yang Libin, Wang Zehu, Li Bowen, Zhang Weixin, Wang Xin, Siringan Mark John, Li Xue, Zhao Ruili, Huang Dongling, Liao Wanwen, Wang Chunru, Bai Chunli

Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma

抗PD-1/PD-L1、VEGF和CTLA-4阻断对肿瘤免疫微环境的独特调节,为肝细胞癌的三联疗法提供了理论依据。

Iwamoto, Hideki; Koga, Hironori; Kawaguchi, Takumi

Endogenous VEGF signaling acts as a guardian of human primed pluripotency

内源性VEGF信号传导是人类多能性的守护者

Wu, Xu; Wen, Chunsheng; Zhu, Chaonan; Jiao, Huiyuan; Xin, Chenge; Jiang, Haokun; Tong, Ran; Huang, Yuwei; Yuan, Liyun; Shao, Min; Zhao, Hanzhi; Gu, Junjie; Wu, Qiong; Zhang, Feng; Wang, Han; Zhou, Yifan; Liao, Bing; Li, Lingjie; Jin, Ying; Li, Hui

Retraction Note: SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis

撤稿声明:VEGFR2的SUMO化修饰调控其细胞内转运和病理性血管生成。

Zhou, Huanjiao Jenny; Xu, Zhe; Wang, Zongren; Zhang, Haifeng; Zhuang, Zhen W; Simons, Michael; Min, Wang

NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss

NKG2D 上调可增强肿瘤对联合抗 PD-1 和抗 VEGF 疗法的敏感性,并预防听力损失。

Lu, Simeng; Yin, Zhenzhen; Wu, Limeng; Sun, Yao; Chen, Jie; Wu, Lai Man Natalie; Oblinger, Janet L; Blake, Day C; Xiu, Bingyu; Landegger, Lukas D; Seist, Richard; Ho, William; Jones, Adam P; Muzikansky, Alona; Stankovic, Konstantina M; Plotkin, Scott R; Chang, Long-Sheng; Xu, Lei